REQUEST A DEMO
Total
USD $0.00
Search more companies

D.O.O. Fm Pharm Subotica (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: D.O.O. Fm Pharm Subotica Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

D.O.O. Fm Pharm Subotica is based in Serbia. The head office is in Subotica. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on December 26, 1995. The total number of employees is currently 22 (2023). From the latest financial highlights, D.O.O. Fm Pharm Subotica reported a net sales revenue increase of 20.79% in 2023. Its’ total assets recorded a growth of 10.66%. The enterprise’s net profit margin increased by 15.27% in 2023.

Headquarters
Vuka Mandusica 39 A
Subotica; North Backa; Postal Code: www.fmpharm.co.rs

Contact Details: Purchase the D.O.O. Fm Pharm Subotica report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the D.O.O. Fm Pharm Subotica report to view the information.
Outstanding Shares:
Purchase the D.O.O. Fm Pharm Subotica report to view the information.
Registered Capital:
Purchase the D.O.O. Fm Pharm Subotica report to view the information.
Incorporation Date:
December 26, 1995
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after D.O.O. Fm Pharm Subotica report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
20.79%
Total operating revenue
21.12%
Operating profit (EBIT)
87.31%
EBITDA
63.33%
Net Profit (Loss) for the Period
81.26%
Total assets
10.66%
Total equity
11.68%
Operating Profit Margin (ROS)
12.87%
Net Profit Margin
15.27%
Return on Equity (ROE)
4.05%
Quick Ratio
4.99%
Cash Ratio
2.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?